MARKET

NKTR

NKTR

Nektar
NASDAQ

Real-time Quotes | Nasdaq Last Sale

20.17
-0.17
-0.84%
After Hours: 20.29 +0.12 +0.59% 17:33 09/18 EDT
OPEN
20.51
PREV CLOSE
20.34
HIGH
20.55
LOW
19.95
VOLUME
2.00M
TURNOVER
--
52 WEEK HIGH
28.60
52 WEEK LOW
13.63
MARKET CAP
3.61B
P/E (TTM)
-8.2722
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average NKTR stock price target is 31.00 with a high estimate of 80.00 and a low estimate of 17.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About NKTR
Nektar Therapeutics is a biopharmaceutical company that discovers and develops medicines in areas of high unmet medical need. The Company's research and development pipeline of new investigational drugs includes treatments for cancer and autoimmune disease. It leverages its chemistry platform to discover and design new drug candidates. These drug candidates utilize its polymer conjugate technology platforms, which are designed to enable the development of new molecular entities that target known mechanisms of action. Its programs include Immuno-oncology (I-O), Immunology, and Oncology-ONZEALD. It is developing medicines designed to directly or indirectly modulate the activity of key immune cells, such as cytotoxic T cells and Natural Killer (NK) cells, to increase their numbers and improve their function to recognize and attack cancer cells.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Nektar Therapeutics stock information, including NASDAQ:NKTR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NKTR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NKTR stock methods without spending real money on the virtual paper trading platform.